SUSANA MANDEL: Open Payments
NPI 1982032439 · AVENTURA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,683 in 105 payments from 20 companies in 2025. Trend: 2023 $1,333 · 2024 $1,494 · 2025 $1,683
Food & beverage: $1,673Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $268 |
| GENZYME CORPORATION | 6 | $195 |
| Janssen Biotech, Inc. | 10 | $171 |
| Arcutis Biotherapeutics, Inc. | 18 | $165 |
| PFIZER INC. | 12 | $164 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 4 | $91 |
| Lilly USA, LLC | 3 | $86 |
| UCB, Inc. | 3 | $82 |
| Novartis Pharmaceuticals Corporation | 3 | $70 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $68 |
Products named: DUPIXENT, TREMFYA, Zoryve, SKYRIZI, CIBINQO, RINVOQ, EBGLYSS, Bimzelx.
Industry payments across FL — which companies pay providers there.
